Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.825
-0.105 (-5.45%)
Dec 3, 2024, 1:39 PM EST - Market open
PACB Employees
Pacific Biosciences of California had 796 employees as of December 31, 2023. The number of employees increased by 27 or 3.51% compared to the previous year.
Employees
796
Change (1Y)
27
Growth (1Y)
3.51%
Revenue / Employee
$217,521
Profits / Employee
-$495,276
Market Cap
499.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Organogenesis Holdings | 862 |
Treace Medical Concepts | 516 |
MeiraGTx Holdings | 425 |
Pharming Group | 382 |
Allogene Therapeutics | 233 |
Alumis | 109 |
PureTech Health | 90 |
Terns Pharmaceuticals | 66 |
PACB News
- 20 days ago - Pacific Biosciences' Cost Cuts Won't Offset Rising Competition - Seeking Alpha
- 24 days ago - PacBio to Present at Upcoming Investor Conferences - GlobeNewsWire
- 25 days ago - Pacific Biosciences of California, Inc. (PACB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028 - GlobeNewsWire
- 26 days ago - PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop - GlobeNewsWire
- 4 weeks ago - The Schall Law Firm Encourages Investors With Losses To Join An Inquiry Into Pacific Biosciences of California Inc For Fraud - Accesswire
- 4 weeks ago - Pacific Biosciences of California, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 4 weeks ago - The Schall Law Firm Encourages Investors To Join An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud - Accesswire